{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:47:51Z","timestamp":1777614471825,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"vor","delay-in-days":2565,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Sci-Tech Office of Guangdong Province","award":["2008B060600019"],"award-info":[{"award-number":["2008B060600019"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.breast.2012.07.004","type":"journal-article","created":{"date-parts":[[2012,7,24]],"date-time":"2012-07-24T18:09:12Z","timestamp":1343153352000},"page":"657-661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Predictive value of breast cancer molecular subtypes in Chinese patients with four or more positive nodes after postmastectomy radiotherapy"],"prefix":"10.1016","volume":"21","author":[{"given":"San-Gang","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen-Yu","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan-Xin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xun-Xing","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.breast.2012.07.004_bib1","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/annonc\/mdm271","article-title":"Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007","volume":"18","author":"Goldhirsch","year":"2007","journal-title":"Ann Oncol"},{"issue":"14","key":"10.1016\/j.breast.2012.07.004_bib2","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJM199710023371401","article-title":"Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish breast cancer cooperative group 82b trial","volume":"337","author":"Overgaard","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"9165","key":"10.1016\/j.breast.2012.07.004_bib3","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(98)09201-0","article-title":"Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish breast cancer cooperative group DBCG 82c randomised trial","volume":"353","author":"Overgaard","year":"1999","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.breast.2012.07.004_bib4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/jnci\/djh297","article-title":"Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial","volume":"97","author":"Ragaz","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"19","key":"10.1016\/j.breast.2012.07.004_bib5","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"Sorlie","year":"2001","journal-title":"Proc Natl Acad Sci U.S.A."},{"issue":"21","key":"10.1016\/j.breast.2012.07.004_bib6","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","article-title":"Race, breast cancer subtypes, and survival in the Carolina breast cancer study","volume":"295","author":"Carey","year":"2006","journal-title":"JAMA"},{"issue":"18","key":"10.1016\/j.breast.2012.07.004_bib7","doi-asserted-by":"crossref","first-page":"10393","DOI":"10.1073\/pnas.1732912100","article-title":"Breast cancer classification and prognosis based on gene expression profiles from a population-based study","volume":"100","author":"Sotiriou","year":"2003","journal-title":"Proc Natl Acad Sci U.S.A"},{"issue":"1","key":"10.1016\/j.breast.2012.07.004_bib8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10549-009-0663-z","article-title":"Molecular predictors of efficacy of adjuvant weekly paclitaxel in early breast cancer","volume":"123","author":"Martin","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"10.1016\/j.breast.2012.07.004_bib9","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1200\/JCO.2008.18.1024","article-title":"Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial","volume":"27","author":"Hugh","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"16","key":"10.1016\/j.breast.2012.07.004_bib10","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1158\/1078-0432.CCR-04-2421","article-title":"Breast cancer molecular subtypes respond differently to preoperative chemotherapy","volume":"11","author":"Rouzier","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.breast.2012.07.004_bib11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10549-008-0096-0","article-title":"Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients","volume":"115","author":"Yin","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2012.07.004_bib12","series-title":"AJCC cancer staging manual","author":"Green","year":"2006"},{"issue":"7","key":"10.1016\/j.breast.2012.07.004_bib13","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1200\/JCO.1999.17.7.1983","article-title":"Specificity of Hercep test in determining HER-2\/neu status of breast cancers using the United States food and drug administration-approved scoring system","volume":"17","author":"Jacobs","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.breast.2012.07.004_bib14","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1200\/JCO.2007.14.5565","article-title":"Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish breast cancer cooperative group","volume":"26","author":"Kyndi","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.breast.2012.07.004_bib15","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.ijrobp.2010.03.038","article-title":"Triple-negative or HER2-positive status predicts higher rates of locoregional recurrence in node-positive breast cancer patients after mastectomy","volume":"80","author":"Wang","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.breast.2012.07.004_bib16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ejso.2011.04.014","article-title":"Prognostic significance of molecular subtype in T1N0M0 breast cancer: Korean experience","volume":"37","author":"Kim","year":"2011","journal-title":"Eur J Surg Oncol"},{"issue":"14","key":"10.1016\/j.breast.2012.07.004_bib17","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1200\/JCO.2007.14.4287","article-title":"Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy","volume":"26","author":"Nguyen","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.breast.2012.07.004_bib18","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s10549-011-1495-1","article-title":"Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation","volume":"128","author":"Panoff","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"16","key":"10.1016\/j.breast.2012.07.004_bib19","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1158\/1078-0432.CCR-04-0220","article-title":"Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma","volume":"10","author":"Nielsen","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.breast.2012.07.004_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cncr.22381","article-title":"Prognostic markers in triple-negative breast cancer","volume":"109","author":"Rakha","year":"2007","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.breast.2012.07.004_bib21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.breast.2006.09.003","article-title":"The basal subtype of breast carcinomas may represent the group of breast tumors that could benefit from EGFR-targeted therapies","volume":"16","author":"Siziopikou","year":"2007","journal-title":"Breast"},{"issue":"4","key":"10.1016\/j.breast.2012.07.004_bib22","first-page":"353","article-title":"Targeting the phosphatidylinositol 3-kinase\/Akt pathway for enhancing breast cancer cells to radiotherapy","volume":"2","author":"Liang","year":"2003","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"10.1016\/j.breast.2012.07.004_bib23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0360-3016(94)90523-1","article-title":"Effect of epidermal growth factor on the growth and radiation sensitivity of human breast cancer cells in\u00a0vitro","volume":"30","author":"Wollman","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.breast.2012.07.004_bib24","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1634\/theoncologist.2008-0001","article-title":"Trastuzumab in the adjuvant treatment of early-stage breast cancer: a systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Dahabreh","year":"2008","journal-title":"Oncologist"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977612001506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977612001506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:29:10Z","timestamp":1760776150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977612001506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0960977612001506"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2012.07.004","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive value of breast cancer molecular subtypes in Chinese patients with four or more positive nodes after postmastectomy radiotherapy","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2012.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}